1. GSK Withdraws Autism Drug Application, Ending Trump-Backed Bid for FDA Approval
GSK has abruptly withdrawn its application to the U.S. Food and Drug Administration for an autism spectrum disorder drug, a candidate that had previously received high-profile backing from former President Donald Trump. The withdrawal comes just weeks after the pharmaceutical giant submitted the application, signaling ...